Rewire

ReWire is leveraging tissue-specific expression to address genetic diseases

rewire.co.il

Biotech & Life Sciences

Sector

Seed

Stage

Biotech partnerships with pharma

Model

01Company Overview

ReWire is leveraging tissue-specific expression to address genetic diseases. Their proprietary TRANCER technology allows for precise gene expression within the correct cellular contexts, potentially transforming treatment approaches for autoimmune disorders and other complex conditions.

02Team

EB

Elisa Barrow

Founder

03Backed By1 investor

RP

Is this your company? Claim your profile

Renegade Partners

→

04Recent Activity

FROM Renegade Partners

Portfolio company Rewire exited.

EXIT·pitchbook.com

JAN 2025

05Similar Companies

MB

Mirai Bio

Biotech & Life Sciences

→

CM

CREATE Medicines

Biotech & Life Sciences

→

B

BreezeBio

Biotech & Life Sciences

→

A

A-SEEDS

Biotech & Life Sciences

→

P

ParcelBio

Biotech & Life Sciences

→

06Startup DNA

13

signals

Sectors
Business Model
Technology
Customers
Positioning